EU seeks advice on Sanofi's response to mismarketing claim
6 Articles
6 Articles
Commission seeks feedback on commitments offered by Sanofi over possible anticompetitive conduct regarding the promotion of a flu vaccine for vulnerable patients - The European Sting - Critical News & Insights on European Politics, Economy, Foreign Affairs, Business & Technology - europeansting.com
(Credit: UNsplash( This article is brought to you in association with the European Commission. The European Commission invites comments on commitments offered by Sanofi to address competition concerns regarding a communication campaign that has possibly disparaged the only rival flu vaccine recommended for vulnerable patients with risk factors. The Commission’s investigation Sanofi, headquartered in France, is a multinational company active in t…
The Community Executive now gives a deadline of 21 August for other interested parties in the case to submit their comments on the changes proposed by Sanofi; commitments which, if validated by Brussels, will be in force until March 2030 and will be supervised by a representative mandated by the Community services themselves.
After government probe, Sanofi offers to end disparaging claims against CSL flu shot in Europe
Two weeks after the European Commission launched an investigation into Sanofi, the French drugmaker has offered to stop making negative claims about a rival drugmaker's flu vaccine. The dispute centered on Sanofi's enhanced flu vaccine ...
Coming in from the cold: The Briefing for 8 July 2026
Drugmaker Sanofi has agreed to take its medicine and remedy EU allegations that it unlawfully disparaged a rival’s flu vaccine. In the hope of walking away from the investigation without an infringement finding, it has promised to rectify past negative marketing and refrain from running similar campaigns in future without evidence. Also in The Briefing, France’s antitrust watchdog imposes an interim injunction on Meta, Booking proposes remedies …
The European Commission today opened a public consultation on commitments by French pharmacist Sanofi after an investigation into alleged abuse of a dominant position in promoting its influenza vaccine for vulnerable people in the European Union (EU).
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium


